Alaunos Therapeutics: CEO Weis Holger received 23,564 shares

What happened Weis Holger, CEO, received 23,564 shares of common stock as an award/grant on Oct 6, 2026 at $0.74 per share, for a total value of $17,541. The Form 4 reporting this transaction was filed on Oct 8, 2026.

Key details

• Transaction date and price: Oct 6, 2026 at $0.74 per share (transaction code A: award/grant).
• Shares owned after the transaction: not reported in the filing.
• Footnote F1: represents shares of common stock issued in lieu of net salary.
• Filing date: Form 4 filed Oct 8, 2026.

Why it may matter

• These shares were issued in lieu of salary and therefore were not a purchase or sale executed on the open market.
• A filing does not show why the insider traded or why the company acted.